Free Trial
→ Do this Before Elon’s Reveal on January 22nd (From Brownstone Research) (Ad) Free SLN Stock Alerts

Silence Therapeutics (SLN) SEC Filings & 10K Form

Silence Therapeutics logo
$6.51 -0.23 (-3.41%)
(As of 12/17/2024 ET)
Compare

Recent Silence Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
12/09/2024
7:12 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:24 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form F-3ASR
08/15/2024
8:05 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
5:51 PM		Invus Global Management, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
06/27/2024
6:40 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:38 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:41 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
1:21 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
11:15 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form EFFECT
05/08/2024
4:14 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form DEL AM
05/01/2024
3:37 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
7:36 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
6:00 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
7:52 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2024
6:10 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:12 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
8:54 AM		Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
02/14/2024
7:55 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
02/12/2024
5:15 PM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
02/09/2024
4:05 PM		Artal International S.C.A. (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLN) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners
Trump’s Secret Manhattan Project
On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...
Banyan Hill Publishing | Sponsored
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Huge Alerts | Sponsored
How this >10-cent coin is going to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Healthcare Takes A Big Step Forward With The Help of A.I.
To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...
Wall Street Star | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Seeing is believing…
Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored